.
Natterer and colleagues now demonstrate that this phenomenon can arise in a single Ho atom. Even more impressively, they show that the atom's magnetic state can be written and read using a scanning tunnelling microscope. The authors first apply a high voltage (above about 150 millivolts) to the microscope tip to flip the atom's spin 7 -this is the writing process. Because the tip is magnetic, electrical conductance through the probed atom varies depending on the direction of the atom's spin with respect to the magnetization of the tip. The authors then read the atom's magnetic state by measuring this conductance 8 . They show that if low voltages (below about 75 mV) are used, the magnetic state can be stable for many hours.
It is often assumed that a system is unaffected by the process of taking measurements. However, this is not the case for experiments that use a scanning tunnelling microscope, in which what is actually probed is a larger system that comprises the tip, the targeted atom or molecule and a substrate. To prove un ambiguously that the observed changes in conductance are caused by spin flips, Natterer and colleagues use a complex architecture in which the Ho atom is deposited alongside an iron (Fe) atom on a MgO bilayer that isolates the two atoms from a silver substrate (Fig. 1) . The authors then use an ingenious scanning probe microscopy technique -described in a study published this year by the same research group 9 -to probe the dipolar magnetic field generated by the Ho atom.
By applying a radio-frequency voltage from the microscope tip to the Fe atom, Natterer et al. detect an anomalous change in conductance when the frequency of the applied voltage matches the 'Larmor' frequency of the Fe atom's spin, which causes the spin to flip. In this way, the authors perform a sort of 'single-spin' version of a spectroscopic technique called electron paramagnetic resonance, which is another remarkable achievement of their research group 10 . Because the Larmor frequency depends on the local magnetic field, the Fe atom 'senses' the magnetic state of the Ho atom, whose spin dynamics are no longer perturbed by the tunnelling current.
Natterer and collaborators find that the magnetic field generated by the Ho atom is stable for several hours, including at liquidhelium temperatures. Moreover, by placing two Ho atoms at slightly different distances from the Fe-atom sensor, the authors can detect the frequency shift associated with the four possible spin combinations, representing the four numbers that can be stored in a two-bit memory.
Although Natterer and colleagues' work is still far from having real-world applications, their advancement of scanning probe microscopy techniques has shown that the storage and retrieval of magnetic information + T cells often become dysfunctional, entering a state known as exhaustion, during certain chronic infections or when they enter a suppressive tumour microenvironment 1 . Although advances in immunotherapy have revealed that the immune system can be harnessed to fight cancer and other chronic diseases, much remains to be learnt about how T cells become dysfunctional and how they might be revitalized. Writing in Science, Pauken et al. 2 and Sen et al. 3 describe key molecular changes that occur in exhausted T cells. Their findings will improve our understanding of how these cells develop and whether their state can be manipulated by certain immunotherapies.
When CD8 The inhibitory receptor proteins desensitize the cells so that they do not respond to the presence of the specific antigen molecule that they usually recognize.
Antibody-mediated blockade of these inhibitory receptor proteins, such as PD-1 or its ligand the PD-L1 protein, has emerged as a transformative mode of cancer immunotherapy, removing the 'brakes' on a T cell's immune response to boost antitumour immunity and provide durable tumour regression for a subset of people treated 6 . However, central questions remain about such immunotherapies. Are exhausted T cells in an irreversible developmental state, or can blockade of PD-1 and PD-L1 signalling induce long-term reprogramming to return them to being functional T cells known as effector T cells that can launch a productive immune response? One way in which such changes in developmental state might be monitored is by analysing epigenetic changes, the structural alterations that occur in the DNA-protein complex called chromatin.
Pauken et al. and Sen et al. dive into the genetic underpinnings of CD8
+ T-cell exhaustion, examining the cells' transcriptional and epigenetic states from the onset of exhaustion through to subsequent treatment with anti-PD-L1 blockade 5, 6 . As CD8 + T cells become exhausted, many changes occur to their
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The chronicles of T-cell exhaustion
T cells of the immune system often fail to target cancer cells because they enter a dysfunctional state known as exhaustion. Molecular analysis of T-cell exhaustion provides insights into the clinical use of these cells.
in a single atom is feasible. Several issues need to be resolved. In terms of reading and writing data, the techniques involved are not the most user-friendly or affordable. Even if other sensing methods are developed, the peculiar magnetic properties of Ho atoms exploited by the authors can be realized only in extreme conditions, such as in an ultrahigh vacuum.
In this respect, the molecular approach, which is at the heart of this research field, could assist us by providing chemically stable objects that can be robustly tethered to a surface. However, in addition to efficient control of the magnetic anisotropy 3 and molecular vibrations 11 , interactions between the mol ecule and its surroundings must be maintained to encode and read information. These are antithetical requirements whose fulfilment will not be straightforward. ■ transcriptional profile, and extensive changes to their chromatin also occur 7 . The authors used mice infected with chronic lymphocytic chorio meningitis virus to examine the changes to messenger RNA transcription and chromatin structure that occur in exhausted T cells over time. Both teams observed that exhausted CD8 + T cells acquire epigenetic modifications that are distinguishable from those of effector T cells. Pauken et al. observed that the exhausted epigenetic state is surprisingly unresponsive to the effects of PD-L1 antibody blockade. Therefore, although antibody treatment can revitalize an exhausted T cell's functional state, the chromatin of the treated cell does not reacquire the epigenetic characteristics of an effector cell (Fig. 1) .
Roberta Sessoli is in the Department
Using a technique to monitor chromatin structure, Sen et al. identified a genomic region that is associated with chromatin changes specific to the exhausted state. In this region, located 23.8 kilobases before the start of the Pdcd1 gene that encodes the PD-1 receptor, Sen and colleagues identified potential binding sites for RAR, T-bet and Sox3 transcription factors that regulate gene expression. When the authors mutated the proposed transcriptionfactor binding sites, PD-1 expression in immune cells called lymphocytes was suppressed. The result suggests that this genomic region may be an enhancer, a regulatory element that drives expression of nearby genes. However, the in vivo role of this region in regulating PD-1 expression and T-cell function remains unknown, and the DNA sequence of the region does not seem to be evolutionarily conserved in humans, potentially limiting the direct clinical relevance of this observation. Nonetheless, the principle of fine-tuning T-cell function to limit exhaustion through the deletion of an enhancer region might be worth exploring for the human PDCD1 gene in a therapeutic context. Given that deletion of the entire Pdcd1 gene in mice counter-intuitively enhances T-cell exhaustion and cell death over time 8 , an approach pinpointing enhancer deletion might be the best way to limit exhaustion-specific changes affecting expression of this key regulator, and thereby enable a prolonged T-cell effector response.
Pauken et al. examined the transcriptional and epigenetic changes that occur over time in exhausted CD8 + T cells treated with antibodies that block the PD-1 pathway. During antibody treatment, the cells' gene-expression profile was more similar to that of an effector T cell 9 . However, once treatment ceased, the CD8 + T cells reverted to a transcriptional profile characteristic of the exhausted state, indicating that they had not developed into either effector T cells or long-lasting memory T cells, which can enable an efficient response to subsequent encounters with the antigen. This result is reminiscent of previous work showing that, during conditions of abnormally low levels of lymphocytes, dormant self-reactive T cells can briefly enter an effector state, only to return to their dormant state 10 , a finding suggestive of epigenetic stability in dysfunctional T cells. If human T cells behave in a similar way to the mouse T cells studied by Pauken and colleagues, then clinical antibody treatments blocking the PD-1 pathway would not be able to convert antibodyrevitalized human T cells into long-lasting effector cells or memory T cells.
Despite the failure of anti-PD-1 blockade to induce large-scale, long-term remodelling of the epigenome of exhausted CD8 + T cells, Pauken et al. note that one key memory trait, an increase in expression of the IL-7 receptor protein, is modestly augmented by anti-PD-L1 antibody treatment. This finding led the authors to test whether IL-7 treatment could improve the therapeutic effects of PD-1 or PD-L1 blockade, and this was indeed the case. This result highlights the power of studying molecular mechanisms in improving the rational design of combination therapies that can be translated to the clinic.
An important outcome of the research by Sen, Pauken and their respective colleagues is the identification of potential ways of enhancing T-cell effector function. Pauken et al. observed that effector genes in both exhausted and effector CD8 + T cells have regions of accessible chromatin that might allow the reengagement of crucial transcription factors, such as NFAT, AP-1 or NF-κB, that might bind reinvigorated CD8 + T cells 11 . Perhaps combining T-cell antibody treatment with the reactivation of these transcription factors could aid the expression of effector genes.
Although the two studies have revealed how T-cell exhaustion occurs at the epigenetic level and how it might be combated, the unchanging nature of the epigenetic state characteristic of exhaustion presents a significant challenge. Many promising small-molecule inhibitors that target the epigenetic state are currently in early clinical trials 12 , and may indeed have a role in future therapies to revitalize dysfunctional T cells. However, the most significant advances will arise through the continued study of the molecular underpinnings of exhaustion, providing scientists and clinicians with the knowledge necessary to design better therapeutic approaches. Through these efforts, we can write a new chapter in the chronicles of T-cell exhaustion, in which our T cells emerge victorious in the fight against chronic viral infection and cancer. ■ Robert A. Amezquita 
